生物活性成分市场－全球产业规模、份额、趋势、机会、预测：按产品、应用、地区和竞争对手划分，2021-2031年

全球生物活性成分市场预计将从 2025 年的 1,751.1 亿美元大幅成长至 2031 年的 2,838.1 亿美元，复合年增长率为 8.38%。

这些成分，包括益生菌、 Omega-3脂肪酸和植物化学物质等天然来源物质，不仅提供基本的营养，还能产生调节代谢过程的生物效应。推动这一成长趋势的关键因素包括全球文明病的增加以及消费者行为向预防性医疗保健策略的显着转变。此外，随着世界人口老化，对营养干预的需求持续增长，从而推动了对添加了这些健康促进成分的营养补充剂和机能性食品的持续需求。

儘管存在这些积极因素，但由于有关健康益处声明的法规结构严格且不一致，该行业仍面临许多挑战。这往往导致合规成本高昂和产品上市延迟。这些法规的复杂性要求产品在进入各个国际市场之前，必须经过广泛的科学检验以证明其有效性。全球EPA和DHA Omega-3组织（GO-EPA）强调了该领域关键细分市场的经济重要性，并报告称，到2024年，全球EPA和DHA Omega-3原材料市场规模将达到23.8亿美元。

市场驱动因素

消费者对机能性食品和饮料日益增长的需求正在改变生物活性成分产业，而这种需求的驱动力源自于消费行为的根本性转变——从被动治疗转向主动健康管理。人们越来越重视饮食，将其作为维持健康的主要手段，并积极寻求富含抗氧化剂、胜肽和益生菌的产品，以解决免疫力和消化系统健康等特定问题。这种行为转变迫使製造商从生产标准食品转向生产高价值功能性产品，从而推动了对经科学验证的化合物的需求。根据Granvia Nutritional发布的2024年1月零食消费趋势分析报告，全球61%的消费者持续选择健康零食，显示功能性营养正成为主流。

同时，消费者对天然和植物性成分日益增长的偏好是市场成长的关键驱动力，迫使供应商不断改进植物萃取技术和洁净标示解决方案。在消费者对合成添加剂的批评日益增多的背景下，各大品牌正以植物来源的生物活性物质取代人工成分，从而确保标籤透明并符合道德标准。这一趋势促使消费者普遍倾向于选择被认为本质上安全的成分，植物性食品协会 (PBFA) 2024 年 5 月的报告也印证了这一点，该报告估计美国植物来源食品零售市场规模为 81 亿美元。此外，国际食品资讯理事会 (IFIC) 2024 年 6 月的调查报告显示，71% 的美国人计划增加蛋白质摄取量，这反映出人们对营养的日益关注正在推动该行业的发展。

市场挑战

围绕着健康声明的严格且不一致的监管体系，对全球生物活性成分市场的成长构成重大障碍。製造商身处复杂的市场环境，不同地区的核准标准差异显着，同一成分在不同地区往往需要进行多项高成本的科学测试才能获得认证。这种缺乏统一性的做法，大幅增加了遵循成本，延缓了创新功能性成分的商业化进程，并使企业对那些以核准程序严格或不明确着称的市场望而却步。因此，这些高昂的财务壁垒限制了竞争，并延缓了新型生物活性解决方案的推出。

这些监管挑战限制了已在特定区域市场取得成功的产品的国际分销，直接削弱了市场潜力。该行业庞大的规模凸显了这些贸易管道障碍造成的机会损失。例如，根据美国植物委员会 (ABC) 预测，2024 年美国草药膳食补充剂的零售额将达到创纪录的 132.3 亿美元，凸显了巨大的消费者需求。然而，缺乏统一的全球标准严重限制了这些高需求品类的跨国扩张，从而阻碍了整个产业的收入成长。

市场趋势

将精准发酵技术应用于非动物性生物活性物质的生产，正在重塑供应链，实现胶原蛋白、乳铁蛋白和人乳低聚醣等复杂化合物的规模化生产，而这些化合物先前均来自动物。该技术能够设计微生物并合成相同的生物活性分子，有效将生产与畜牧业脱钩，同时应对紧迫的永续性和供应链稳定性挑战。这项转型吸引了大量资金用于加强基础建设和商业化进程，凸显了该产业的可持续发展潜力。正如良好食品研究所（Good Food Institute）在2025年6月指出的那样，2024年全球发酵公司获得了6.51亿美元的私人融资，用于推动这些先进生产平台的发展。

同时，人工智慧在成分发现领域的应用正在革新研发模式，使其从传统的试验误法转向预测性、数据驱动的策略。透过利用机器学习演算法，科学家可以快速分析庞大的植物基因组资料库，识别出具有显着健康益处的特定植物化学物质和胜肽类，这些物质先前要么无法检测到，要么提取成本过高。这种技术协同作用显着缩短了研发週期，并揭示出能够满足特定健康需求（例如代谢支持和肌肉恢復）的强效生物活性物质。作为该领域投资的典型例证，Nuritas公司于2024年12月宣布已筹集4,200万美元，用于扩展其人工智慧驱动的平台，该平台专注于智慧发现天然存在的生物活性成分。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球生物活性成分市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品成分（膳食纤维、维生素、 Omega-3多元不饱和脂肪酸、植物萃取物、矿物质、类胡萝卜素/抗氧化剂、益生菌、其他）
  • 按应用领域（功能性食品和饮料、营养补充品、临床营养、个人护理、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美生物活性成分市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲生物活性成分市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区生物活性成分市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲生物活性成分市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲生物活性成分市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章 全球生物活性成分市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Sabinsa Corporation
• Archer Daniels Midland Company（ADM）
• BASF SE
• Cargill Inc.
• Ingredion Inc.
• Ajinomoto Co., Inc.
• Owen Biosciences Inc.
• Nuritas Ltd.
• DuPont de Nemours, Inc.

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Bioactive Ingredients Market is projected to expand significantly, rising from USD 175.11 Billion in 2025 to USD 283.81 Billion by 2031, reflecting a CAGR of 8.38%. These ingredients, which include naturally occurring substances like probiotics, omega-3 fatty acids, and phytochemicals, offer biological benefits that extend beyond basic nutrition to modulate metabolic processes. Key factors driving this trajectory include the rising global incidence of chronic lifestyle-related diseases and a marked consumer pivot toward preventative health strategies. Furthermore, an aging global demographic is fueling a consistent need for nutritional interventions, thereby sustaining demand for nutraceuticals and functional foods enhanced with these health-promoting components.

Despite these positive indicators, the industry encounters substantial obstacles due to rigorous and inconsistent regulatory frameworks regarding health claims, which often inflate compliance costs and postpone product launches. This regulatory complexity necessitates extensive scientific validation to prove efficacy before products can be introduced into various international markets. Highlighting the economic significance of major segments within this domain, the Global Organization for EPA and DHA Omega-3s reported that the global market for EPA and DHA omega-3 ingredients reached a value of US$2.38 billion in 2024.

Market Driver

The escalating appetite for functional foods and beverages is transforming the bioactive ingredients sector, propelled by a fundamental consumer shift from reactive treatments to proactive wellness management. Individuals are increasingly utilizing diet as a primary tool for health maintenance, actively seeking products enriched with antioxidants, peptides, and probiotics to target specific issues like immunity and digestive health. This behavioral change compels manufacturers to upgrade standard grocery offerings into value-added functional goods, thereby boosting the demand for scientifically backed compounds. According to Glanbia Nutritionals' January 2024 analysis of snacking trends, 61% of global consumers consistently look for healthier snack options, demonstrating the mainstream adoption of functional nutrition.

Concurrently, the rising inclination toward natural and plant-based ingredients serves as a vital engine for market growth, urging suppliers to advance botanical extraction technologies and clean-label solutions. As consumers become more critical of synthetic additives, brands are substituting artificial elements with plant-derived bioactives to ensure label transparency and align with ethical standards. This trend influences a wide demographic to favor ingredients viewed as inherently safer, as evidenced by the Plant Based Foods Association's May 2024 report, which valued the U.S. plant-based food retail market at US$8.1 billion. Furthermore, the International Food Information Council's June 2024 survey noted that 71% of Americans are striving to increase their protein intake, reflecting the deep nutritional engagement driving this industry.

Market Challenge

Rigorous and disjointed regulatory systems regarding health claims create a significant impediment to the progress of the Global Bioactive Ingredients Market. Manufacturers navigate a convoluted landscape where approval criteria differ widely by region, necessitating multiple costly scientific trials to validate the same ingredient for various territories. This absence of harmonization drastically elevates compliance expenses and retards the commercialization of innovative functional ingredients, frequently deterring companies from engaging with markets known for strict or unclear approval procedures. Consequently, these high financial barriers restrict competition and decelerate the introduction of new bioactive solutions.

These regulatory challenges directly curtail market potential by restricting the international distribution of products that have already achieved success in specific local markets. The magnitude of the sector highlights the opportunities lost due to these obstructed trade avenues. For instance, the American Botanical Council reported that retail sales of herbal dietary supplements in the United States hit a record US$13.23 billion in 2024, illustrating immense consumer demand. However, the lack of unified global standards severely limits the ability of such high-demand categories to scale seamlessly across borders, thereby suppressing the overall revenue growth of the industry.

Market Trends

The integration of precision fermentation for animal-free bioactives is reshaping the supply chain by facilitating the scalable creation of complex compounds, such as collagen, lactoferrin, and human milk oligosaccharides, which were traditionally sourced from animals. This technology permits the engineering of microorganisms to synthesize identical bioactive molecules, effectively decoupling production from livestock farming while addressing urgent sustainability and supply stability issues. This transition is drawing significant capital to bolster infrastructure and commercialization efforts, confirming the sector's enduring potential. As noted by the Good Food Institute in June 2025, fermentation companies globally secured US$651 million in private funding during 2024 to further these advanced production platforms.

In parallel, the application of artificial intelligence in ingredient discovery is revolutionizing research and development, moving it from traditional trial-and-error methods to predictive, data-centric strategies. By utilizing machine learning algorithms, scientists can rapidly analyze extensive plant genomic databases to pinpoint specific phytochemicals and peptides with significant health advantages that were previously undetected or too expensive to extract. This technological synergy drastically reduces development schedules and reveals potent bioactives for specific health needs, such as metabolic support and muscle recovery. Highlighting the investment in this area, Nuritas announced in December 2024 that it had raised US$42 million to broaden its AI-driven platform focused on uncovering intelligent nature-based bioactive ingredients.

Key Market Players

• Sabinsa Corporation
• Archer Daniels Midland Company (ADM)
• BASF SE
• Cargill Inc.
• Ingredion Inc.
• Ajinomoto Co., Inc.
• Owen Biosciences Inc.
• Nuritas Ltd.
• DuPont de Nemours, Inc.

Report Scope

In this report, the Global Bioactive Ingredients Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioactive Ingredients Market, By Product

• Fiber
• Vitamins
• Omega 3 PUFA
• Plant Extracts
• Minerals
• Carotenoids & Antioxidants
• Probiotics
• Others

Bioactive Ingredients Market, By Application

• Functional Food & Beverage
• Dietary Supplements
• Clinical Nutrition
• Personal Care
• Others

Bioactive Ingredients Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioactive Ingredients Market.

Available Customizations:

Global Bioactive Ingredients Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioactive Ingredients Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Fiber, Vitamins, Omega 3 PUFA, Plant Extracts, Minerals, Carotenoids & Antioxidants, Probiotics, Others)
  • 5.2.2. By Application (Functional Food & Beverage, Dietary Supplements, Clinical Nutrition, Personal Care, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Bioactive Ingredients Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bioactive Ingredients Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Bioactive Ingredients Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Bioactive Ingredients Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Bioactive Ingredients Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Bioactive Ingredients Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. France Bioactive Ingredients Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Bioactive Ingredients Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Bioactive Ingredients Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Bioactive Ingredients Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia Pacific Bioactive Ingredients Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Bioactive Ingredients Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Bioactive Ingredients Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Bioactive Ingredients Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Bioactive Ingredients Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Bioactive Ingredients Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. Middle East & Africa Bioactive Ingredients Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Bioactive Ingredients Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Bioactive Ingredients Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Bioactive Ingredients Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. South America Bioactive Ingredients Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Bioactive Ingredients Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Bioactive Ingredients Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Bioactive Ingredients Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Bioactive Ingredients Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Sabinsa Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Archer Daniels Midland Company (ADM)
• 15.3. BASF SE
• 15.4. Cargill Inc.
• 15.5. Ingredion Inc.
• 15.6. Ajinomoto Co., Inc.
• 15.7. Owen Biosciences Inc.
• 15.8. Nuritas Ltd.
• 15.9. DuPont de Nemours, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer